SCHEMBL7461874

SCHEMBL7461874

CCCOc1c(Cl)cc(Cl)c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.40
KDM4E B2RXH2 2/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
HPGD P15428 2/20 0.40
MAPK1 P28482 1/20 0.40
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
CSNK2A1 P68400 2/20 0.39
GABRP O00591 1/20 0.38
GABRD O14764 1/20 0.38
GABRA1 P14867 1/20 0.38
GABRB1 P18505 1/20 0.38
GABRG2 P18507 1/20 0.38
GABRB3 P28472 1/20 0.38
GABRA5 P31644 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19612487 0.86 MAPT (0.44) MAPTKMT2AMEN1KDM4EL3MBTL1
SCHEMBL6474548 0.82 MAPT (0.41) MAPTKMT2AMEN1CYP1A2CYP2C19
SCHEMBL29363872 0.80 ALDH1A1 (0.46) MAPTKMT2AMEN1CYP1A2CYP2C19
SCHEMBL487367 0.80 ALDH1A1 (0.46) MAPTKMT2AMEN1CYP1A2CYP2C19
SCHEMBL1127920 0.78 ALDH1A1 (0.44) MAPTKMT2AMEN1CYP1A2CYP2C19
SCHEMBL19612241 0.78 L3MBTL1 (0.47) MAPTCYP1A2CYP2C19KDM4EL3MBTL1
SCHEMBL20398706 0.77 MAPT (0.44) MAPTKMT2AKDM4EL3MBTL1CSNK2A1
SCHEMBL19612685 0.76 CNR1 (0.47) MAPTKMT2AMEN1L3MBTL1HPGD
SCHEMBL20398447 0.75 EPHX2 (0.42) MAPTKMT2AMEN1KDM4EL3MBTL1
SCHEMBL23271639 0.75 ALDH1A1 (0.41) MAPTCYP1A2CYP2C19KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020107278-A1 Substituted azepino[4,5b]indole derivatives PHARMACIA & UPJOHN COMPANY 2002-08-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107278-A1 Substituted azepino[4,5b]indole derivatives HTR5A, HTR1A, HTR1E MAPT 2666/4885KMT2A 2844/4885MEN1 852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.